Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmonary Bypass

NCT02025621 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

882

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Bypass Grafting
Mitral Valve Surgery
Low Cardiac Output Syndrome

Interventions

DRUG: Levosimendan
DRUG: Placebo

Sponsor

Tenax Therapeutics, Inc.